Watanabe Todd
Watanabe Todd, SR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 4377.000000 shares for an estimated $139466.10. Reported holdings after the transaction were 712826.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Nov 02, 2026
- Filing date
- Nov 04, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 717,203 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ARQT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001628280-26-070381 Common Stock
- Transaction date
- Nov 02, 2026 Filed Nov 04, 2026, 11:38 PM · 2d delay
- Shares
- 4,377 sh $31.86 per share
- Estimated value
- -$139k Computed from shares × price
- Holdings after
- 712,826 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- F2
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby
undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respec…
price within the range set forth in this footnote.
- F3F4F5F6(4 footnotes)
The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to th…
0 other transactions
0 recent txs